HTA Submissions

Accelerate Market Access with Confidence

Navigating the complex and ever-evolving landscape of health technology assessment (HTA) and reimbursement submissions requires precision, strategy, and deep expertise. At RTI Health Solutions, we partner with pharmaceutical and medtech companies to deliver high-impact, evidence-based submissions that meet global regulatory and payer expectations.

Whether you're preparing for the EU Joint Clinical Assessment (JCA), launching in the U.S., or seeking reimbursement in international markets, our integrated team of experts is here to guide you every step of the way.

Health Technology Assessment (HTA) Utility Measures

Not One-Size-Fits-All

Download the Guidance
image of partial globe with country outlines and flags

Comprehensive Support Across the Submission Lifecycle

We offer tailored strategic and technical services to support your product’s journey from early development through post-submission engagement:

  • Strategic Planning & Advisory Services
    • Early advice and stakeholder engagement
    • Post-submission support and payer validation
  • Submission Development
    • Full dossier writing or targeted section development
    • Integration of existing materials or creation of new components
  • Evidence Generation & Analysis

Global Reach, Local Expertise

Our proven track record spans major HTA markets, including:

  • Europe: NICE (UK), SMC, AWMSG, TLV (Sweden), NCPE (Ireland), NoMa (Norway), AMNOG (Germany), Fimea/Hila (Finland), DMC/Amgros/DMA (Denmark)
  • North America: CADTH, INESSS (Canada), AMCP dossiers and ICER preparation (U.S.)
  • Australia: PBAC

We also specialize in multicountry economic modeling, ensuring your core models are efficiently adapted to meet country-specific requirements—saving time, reducing costs, and improving consistency across submissions.

HTA Considerations for Large Language Models in Healthcare
Using Literature Reviews to Reveal the Benefits and Demonstrate the Value of Your Product​
Webinar Content
Join our webinar to explore methodologies that enhance product development, support market access, and demonstrate value through real-world case studies.
Rethinking Health Technology Assessment: Expanding Value Beyond Health Gains and Costs
Insight
Explore how HTA is evolving to include social, ethical, and environmental considerations beyond traditional health and cost metrics.
Surrogate Outcomes in HTA - Accelerating Access to Breakthrough Treatments
Webinar Content
Learn how surrogate outcomes accelerate access to breakthrough treatments, as well as methods, HTA guidance, and real-world examples.

Featured Publications

Meet Our Experts